Prosecution Insights
Last updated: April 19, 2026

William D. Hare

16 pending office actions • 10 clients

Portfolio Summary

16
Total Pending OAs
7
Final Rejections
9
Non-Final OAs

Client Portfolio (10 clients)

Client (Assignee)Pending OAs
Jubilant Draximage Inc. 4
Ottawa Heart Institute Research Corporation 2
Azurity Pharmaceuticals, Inc. 1
Anish Sheth 1
It'S Optimal, LLC 1
Tulex Pharmaceuticals, Inc. 1
Shinkei Therapeutics, Inc. 1
Jubilant Hollisterstier LLC 1
Dynamic Biologics Inc. 1
Jubilant Radiopharma 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19244626 STABLE LIQUID COMPOSITIONS OF NETUPITANT AND PALONOSETRON Azurity Pharmaceuticals, Inc. CORNET, JEAN P 1628 Final Rejection Jun 20, 2025
19046369 Rubidium Elution System Ottawa Heart Institute Research Corporation YANG, YI-SHAN 3798 Non-Final OA Feb 05, 2025
19020677 PHARMACEUTICAL COMPOSITIONS FOR IMAGING, DIAGNOSIS AND TREATMENT OF CANCER Jubilant Draximage Inc. COFFA, SERGIO 1658 Final Rejection Jan 14, 2025
18940433 Albumin Conjugates and Process for Preparation thereof Jubilant Draximage Inc. SCHLIENTZ, LEAH H 1618 Final Rejection Nov 07, 2024
18860949 Recyclable Shipping Pack and Method of and Apparatus for Forming a Shipping Pack for Loose-Fill Produce Unknown WITTENSCHLAEGER, THOMAS M 3731 Non-Final OA Oct 28, 2024
18649911 Endoscopic Bite Block With Compressible Bite Surface Anish Sheth MOK, ANDREW JUN-WAI 3786 Non-Final OA Apr 29, 2024
18542674 HEAT RESISTANT GENERATOR COLUMNS FOR ELUTION SYSTEMS Jubilant Draximage Inc. DONOHUE, SEAN R 1618 Final Rejection Dec 16, 2023
18562998 EXPERT SCORING SYSTEM FOR MEASUREMENT OF SEVERITY, TREATMENT RESPONSE AND PROGNOSIS OF PERIPHERAL ARTERIAL DISEASE Jubilant Draximage Inc. PENG, BO JOSEPH 3797 Final Rejection Nov 21, 2023
18490712 Detachable Three-Piece Eyeglasses Suitable for Single Eyewear Unknown SRIDHAR, SAMANVITHA 2872 Final Rejection Oct 19, 2023
18483574 Tankless Hot Water Heater It'S Optimal, LLC KIM, SANG K 3745 Non-Final OA Oct 10, 2023
18549944 Extended-release compositions comprising atomoxetine Tulex Pharmaceuticals, Inc. LIU, ALLY SHUANG 1611 Non-Final OA Sep 11, 2023
18356972 PARENTERAL TREATMENTS INVOLVING AMINOADAMANTANE DERIVATIVES Shinkei Therapeutics, Inc. CORNET, JEAN P 1628 Non-Final OA Jul 21, 2023
18320115 IMPROVED DOSING METHOD FOR POSITRON EMISSION TOMOGRAPHY IMAGING Ottawa Heart Institute Research Corporation ROBINSON, NICHOLAS A 3798 Final Rejection May 18, 2023
18252354 PREPARATION OF HIGHLY CONCENTRATED ALLERGENIC INTERMEDIATE Jubilant Hollisterstier LLC SPANGLER, JOSEPH RANKIN 1656 Non-Final OA May 09, 2023
18004665 LENALIDOMIDE PRODRUGS, POLYMERIC CONJUGATES, AND FORMULATIONS THEREOF, AND THEIR USES FOR THE TREATMENT OF MULTIPLE MYELOMA Dynamic Biologics Inc. KOSTURKO, GEORGE W 1621 Non-Final OA Jan 06, 2023
17942911 PHARMACEUTICAL COMPOSITIONS FOR IMAGING, DIAGNOSIS AND TREATMENT OF CANCER Jubilant Radiopharma MEJIAS, SAMANTHA LEE 1618 Non-Final OA Sep 12, 2022

Managing William D. Hare's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month